• Home
  • Case Study Solution

Tesla in 2015 Custom Case Solution & Analysis

1. Evidence Brief: Tesla in 2015

Financial Metrics

  • Revenue Growth: Total revenue reached 3.2 billion dollars in 2014, up from 2.01 billion dollars in 2013.
  • Net Income: Reported a net loss of 294 million dollars in 2014, increasing from a 74 million dollar loss in 2013.
  • Research and Development: R and D expenses totaled 464.7 million dollars in 2014, representing 14.5 percent of revenue.
  • Capital Expenditure: Spent 969 million dollars in 2014, primarily for Model X tooling and Gigafactory construction.
  • Market Valuation: Market capitalization fluctuated around 25 to 30 billion dollars in early 2015, despite never posting an annual profit.

Operational Facts

  • Production Volume: Delivered 31655 Model S units in 2014. Target for 2015 set at 55000 units.
  • Manufacturing Base: Primary production located at the Fremont, California plant, a former NUMMI facility with a capacity for 500000 vehicles annually.
  • Battery Production: Broke ground on the Gigafactory in Nevada, a 5 billion dollar joint venture with Panasonic aiming to reduce battery pack costs by 30 percent.
  • Charging Infrastructure: Operated 434 Supercharger stations with 2359 individual stalls across North America, Europe, and Asia by mid-2015.
  • Product Line: Model S (Sedan), Model X (SUV - pending launch), and Model 3 (Mass-market - announced).

Stakeholder Positions

  • Elon Musk (CEO): Maintains the Master Plan to fund low-volume expensive cars with high-volume cheaper cars. Focuses on vertical integration.
  • JB Straubel (CTO): Focuses on battery technology and energy storage as the core competency of the firm.
  • Traditional OEMs: BMW, Mercedes-Benz, and Audi are launching plug-in hybrid variants to compete with Model S.
  • Investors: Divided between those valuing Tesla as a high-growth tech firm and those viewing it as an overvalued automotive manufacturer.

Information Gaps

  • Model 3 Margin Targets: The case lacks specific gross margin projections for the 35000 dollar price point.
  • Competitor Battery Costs: Direct cost comparisons for battery packs from GM or LG Chem are not fully disclosed.
  • Service Revenue: Data on the long-term profitability of the direct-to-consumer service model is absent.

2. Strategic Analysis

Core Strategic Question

  • Can Tesla successfully transition from a niche luxury manufacturer to a high-volume mass-market producer while managing extreme capital intensity and increasing incumbent competition?

Structural Analysis

The automotive industry in 2015 presents high barriers to entry due to capital requirements and regulatory hurdles. However, Tesla has bypassed traditional dealership barriers via direct sales. Supplier power is concentrated in battery cells, which Tesla is addressing through the Gigafactory. Competitive rivalry is intensifying as German luxury brands move from skepticism to active electrification. The threat of substitutes remains low for long-range electric vehicles but high for the broader transportation market including internal combustion engines.

Strategic Options

Option Rationale Trade-offs
Mass Market Acceleration Prioritize Model 3 development to capture first-mover advantage in the 35000 dollar segment. Requires massive capital raises; risks quality issues due to rapid scaling.
Energy Storage Pivot Expand Tesla Energy (Powerwall/Powerpack) to diversify revenue and maximize Gigafactory utilization. Distracts management from vehicle production; enters a different competitive landscape.
Technology Licensing License powertrain and battery tech to traditional OEMs to generate high-margin cash flow. Cedes competitive advantage; turns Tesla into a Tier 1 supplier rather than a brand.

Preliminary Recommendation

Tesla must prioritize the Mass Market Acceleration option. The current valuation is predicated on high-volume growth, not niche luxury sales or battery hardware supply. The Gigafactory is a fixed-cost bet that requires the volume of the Model 3 to achieve the necessary unit cost reductions. Diversification into energy storage should be secondary to vehicle delivery targets.

3. Implementation Roadmap

Critical Path

  • Month 1-6: Finalize Model X production ramp. Resolve falcon-wing door manufacturing bottlenecks to stabilize cash flow from the luxury segment.
  • Month 7-12: Complete Phase 1 of the Gigafactory. Secure lithium and graphite supply chains to prevent production halts.
  • Month 13-18: Unveil Model 3 prototype and open reservation system to secure interest-free capital from deposits.
  • Month 19-24: Tooling installation at Fremont for Model 3 lines, utilizing lessons from Model X delays.

Key Constraints

  • Capital Liquidity: The current burn rate exceeds 100 million dollars per month. Any delay in Model X revenue creates a solvency risk.
  • Supply Chain Reliability: Dependence on specialized components for the Model X increases the risk of work stoppages.
  • Service Capacity: The direct sales model requires a physical service footprint that currently cannot support a 10x increase in vehicle volume.

Risk-Adjusted Implementation Strategy

Execution must focus on de-risking the Model 3. This involves simplifying the design compared to the Model X to avoid engineering-led delays. A contingency fund of 1.5 billion dollars should be raised via equity markets while the stock price remains high to provide a buffer against manufacturing friction. The service network expansion should be phased, starting with mobile service units to reduce the need for expensive real estate.

4. Executive Review and BLUF

BLUF

Tesla is at a breaking point. The transition from the Model S to the Model 3 is not an incremental step but a total transformation of the business model. Success depends entirely on achieving battery cost parity via the Gigafactory and mastering high-volume manufacturing. The current path is high-risk but necessary to justify the market valuation. Leadership must stop adding product complexity and focus exclusively on manufacturing throughput. Failure to deliver the Model 3 on time will result in a liquidity crisis that the current luxury sales cannot fix.

Dangerous Assumption

The single most dangerous assumption is that battery costs will decline linearly with scale regardless of raw material price volatility. If lithium or cobalt prices spike, the 35000 dollar price point for the Model 3 becomes structurally unprofitable, regardless of Gigafactory efficiency.

Unaddressed Risks

  • Execution Overload: Management is attempting to launch a new vehicle (Model X), build a massive factory, and start an energy division simultaneously. Consequence: Median quality drops and delivery timelines slip.
  • Regulatory Shift: Reliance on ZEV credit sales to offset losses is a fragile strategy. If other OEMs launch their own EVs, the market for these credits disappears, removing a vital cash source.

Unconsidered Alternative

The team has not considered a strategic pause on the Energy division. By delaying the Powerwall and Powerpack, Tesla could reallocate engineering talent and capital to ensure the Model 3 launch is flawless. This would prioritize the core automotive brand over a secondary market entry.

Verdict

APPROVED FOR LEADERSHIP REVIEW



Custom Case Solution



Opening Doors for The Little Cocoa Bean Company custom case study solution

Risk and Resilience: Changemakers on the Frontlines of Climate Adaptation custom case study solution

Amar Chitra Katha's Quest for Growth: From Print to Pixels custom case study solution

Evergrande Group: The Largest Bankruptcy in Corporate China custom case study solution

ALDI's Playbook for Retail Success custom case study solution

Airport Blues: Passengers Grounded by Microsoft-CrowdStrike Outage custom case study solution

The Challenge of Administering 75,000 Vaccinations custom case study solution

Indonesia Education Reform: Merdeka Belajar ("Emancipated Learning") custom case study solution

Jorgen Vig Knudstorp: Reflections on LEGO's Transformation custom case study solution

Monde Nissin Corporation: IPO Luck in the Philippines custom case study solution

GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships custom case study solution

Avaya (A) custom case study solution

Richter: Information Technology at Hungary's Largest Pharma custom case study solution

Getting Participant-Centered Learning to Work custom case study solution

Kjell & Company: Electronics Accessories Retail in the Nordics custom case study solution